Carregando...

Trastuzumab Administration in Patients with Metastatic Breast Cancer – Experience of a Large University Breast Center

Background: Administered either alone or in combination with various cytostatic, endocrine or targeted therapies, trastuzumab significantly improves the prognosis of patients with HER2-positive breast cancer. As trastuzumab is effective across multiple lines of therapy in the metastatic setting (tre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Hartkopf, A. D., Brendel, M. H., Wallwiener, M., Taran, F.-A., Brucker, S., Grischke, E.-M.
Formato: Artigo
Idioma:Inglês
Publicado em: Georg Thieme Verlag KG 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4069214/
https://ncbi.nlm.nih.gov/pubmed/24976638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0034-1368244
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!